Skip to main content

Day: December 15, 2021

Otonomo Partners with NXP to Turbocharge Edge Computing on Wheels

New collaboration leverages vehicle edge computing to reduce data processing costs, enhance privacy and expand data-driven capabilities HERZLIYA, Israel and SAN JOSE, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) — Otonomo Technologies Ltd. (Nasdaq: OTMO), a leading mobility intelligence platform provider, today announced it has joined forces with NXP® Semiconductors, to accelerate the time-to-value for the data generated at the vehicle edge. The partnership ensures compatibility and business continuity between NXP’s S32G vehicle network processors at the vehicle edge and the Otonomo Mobility Intelligence Platform in the cloud, to offer a seamless, secure infrastructure for transferring data from vehicle to cloud. It also enables Otonomo to offer new differentiated and connected vehicle data and mobility insights that can accelerate the...

Continue reading

ABVC BioPharma Medical Device Vitargus Receives Taiwan National Innovation Award

Fremont, CA, Dec. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Vitargus®, its vitreous substitute intended to facilitate retina re-attachment surgery, received the 2021 “National Innovation and Renewal of Diligence” award from the Institute for Biotechnology and Medicine Industry (IBMI) of Taiwan. The award was presented at the Taiwan Medical Technology Exhibition on December 2, 2021 at the Taipei Nangang Exhibition Center. Early clinical studies indicate that Vitargus® has unique properties that eliminate the need for post-surgery patient face-down positioning and improves recovery period patient comfort and visual acuity compared to existing...

Continue reading

Alector Announces Appointment of Sara Kenkare-Mitra, Ph.D., as President and Head of Research and Development

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the appointment of Sara Kenkare-Mitra, Ph.D., as President and Head of Research and Development. In this newly created role, Dr. Kenkare-Mitra will lead all aspects of the company’s immuno-neurology and oncology R&D efforts, including oversight of the research, development, clinical, manufacturing, regulatory, and related functions. Dr. Kenkare-Mitra will report to Arnon Rosenthal, Ph.D., Chief Executive Officer of Alector. Dr. Kenkare-Mitra joins Alector from Genentech where, as Senior Vice President, Development Sciences, she served as a member of the research and development leadership team, overseeing the transition of molecules from discovery to...

Continue reading

C-Bond Systems Continues to Strengthen its IP Portfolio as U.S. Patent and Trademark Office Issues Patent No. 16/003,872, Emulsion Compositions and Methods for Strengthening Glass

This newly issued patent is a core patent of C-Bond Systems’ IP portfolio HOUSTON, Dec. 15, 2021 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it continues to strengthen its intellectual property portfolio as the United States Patent and Trademark Office issued Patent No. 16/003,872, Emulsion Compositions and Methods for Strengthening Glass. The Company views this newly issued patent as a core patent of its IP portfolio. “This newly issued patent for glass strengthening is the most important patent we have received to date,” stated Scott R. Silverman, Chairman and CEO of C-Bond. “The patent is the basis for our emulsification surface technology used for C-Bond nanoShield™ and our other products.” Silverman continued, “This patent issuance continues...

Continue reading

Allogene Therapeutics Expands Headquarters to Support Company Growth and Pipeline Innovation

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that it entered into a lease agreement to expand its headquarters in South San Francisco, California. The lease is expected to commence on April 1, 2022, and the additional 47,566 square feet of office and laboratory space will support the growth of its research platform and correlative clinical development activities. “Our team, our research capabilities, and our drive for innovation continue to grow,” said David Chang, M.D., Ph.D., President, Chief Executive Officer and Co-Founder of Allogene. “As we look into 2022 and beyond, this additional space will allow us to advance our broad pipeline...

Continue reading

Ferrellgas Partners, L.P. Reports First Quarter Fiscal 2022 Results

Financial HighlightsGross Profit for the first fiscal quarter increased by $10.8 million compared to the prior year period. Operating Income for the first fiscal quarter increased by 60% compared to the prior year period.Company HighlightsFerrellgas began its partnership with Operation Warm bringing warmth through winter coats to families in need across the United States. Ferrellgas welcomed its newest acquisitions to the Ferrellgas Family: Starlite, located on Long Island, New York, and Northern Cascades, in Washington state. Ferrellgas Management Development Program began its second year and continues to contribute to our performance. This leadership initiative provides an opportunity for excellence in leadership, logistics, and operations management. Ferrellgas acquired a new service mark, Fuel Life Simply.OVERLAND PARK,...

Continue reading

UA Multimedia Announces Launch of Decentralized Exchange (DEX), Targeting Multitrillion-Dollar Cryptocurrency and DeFi Market

IRVINE, CA, Dec. 15, 2021 (GLOBE NEWSWIRE) — UA Multimedia, Inc. (OTC Pink: UAMM), a holding company and solution provider in the areas of blockchain, cryptocurrency, decentralized finance (DeFi), NFT and metaverse, announces the launch of the beta decentralized exchange (DEX), GogiSwap. GogiSwap (https://gogiswap.com) is a decentralized permissionless cryptocurrency exchange.  It connects to most major and many smaller exchanges worldwide to provide users with the needed liquidity for efficient trading and allows them to exchange between 280 cryptocurrencies from over 20 different blockchains. Unlike centralized exchanges such as Coinbase, Binance or Kraken, GogiSwap is a non-custodian exchange and does not require users to provide personal information to open accounts.  All transactions are made via the users’ own digital wallets,...

Continue reading

Tersus Power Sees Revenue Being Generated Through Multiple Channels

ST. PETERSBURG, Fla., Dec. 15, 2021 (GLOBE NEWSWIRE) — Global Technologies, Ltd (OTC Pink: GTLL) (the “Company”), a holding corporation, which, through its subsidiaries, has operations engaged in the online sales of CBD and hemp-related products, the acquisition of intellectual property in the safety and security space, and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, distribution and logistics, is pleased to provide shareholders an update on Tersus Power’s multiple revenue channels. Tersus Power will receive revenue through multiple channels in the hydrogen industry: engineering consulting, sale of the proprietary Modular Hydrogen Fueling Station, sale of standalone components inherit within the Hydrogen Fueling Station and servicing of the Hydrogen Fueling Stations. In the company’s...

Continue reading

Monument Commences Phase 2 Drilling Program at the Murchison Gold Project

Figure 1Murchison Exploration LocationsFigure 2High potential target locations at the Burnakura projectFigure 3A long section looking west through NOA 7/8 showing target location of planned drill holes.Figure 4A long section looking west through NOA 2 showing structure and planned drill hole targets.Figure 5A long section through NOA 1 looking west showing structure and planned drill hole targets.VANCOUVER, British Columbia, Dec. 15, 2021 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” is pleased to announce the commencement of a Phase 2 exploration drilling program at Burnakura, one of the primary Murchison Gold Projects in the Meekatharra area, Western Australia. Together the Phase 2 with the...

Continue reading

Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress

Received feedback from the European notified body after review of Expanded IH submission Pleased with feedback and expect to submit a response to the questions in the next couple of weeks Continue to expect approval in Q1 CY 2022JERSEY, Channel Islands, Dec. 15, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the company received feedback from the European notified body on the Expanded Immunohematology (IH) submission. The Company is pleased with the feedback and expects to submit a response to the questions in the next couple of weeks. “I’m very pleased with the recent news and thankful for progress the team has made with this submission. I’m looking forward to executing on our commercialization in the first quarter of next year,” said Manuel O. Méndez, Chief...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.